Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Dow
Harvard Business School
Baxter
Moodys

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TORSEMIDE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for torsemide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00334386 ↗ Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. Completed Ferrer Internacional S.A. Phase 4 2005-04-01 Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.
NCT00602303 ↗ Bioequivalency Study of Torsemide Tablets Under Fasting Conditions Completed Roxane Laboratories N/A 2003-09-01 The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex┬« Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00602615 ↗ Bioequivalency Study of Torsemide Tablets Under Fed Conditions Completed Roxane Laboratories N/A 2003-09-01 The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex┬« Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00653549 ↗ Bioavailability Study of Torsemide Tablets Under Fasting Conditions Completed Anapharm Phase 1 2001-04-01 To compare the single-dose bioavailability of Torsemide tablets with Demadex
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for torsemide

Condition Name

Condition Name for torsemide
Intervention Trials
Heart Failure 4
Acute Decompensated Heart Failure 2
Congestive Heart Failure 2
Edema 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for torsemide
Intervention Trials
Heart Failure 8
Hypertension 4
Malnutrition 2
Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for torsemide

Trials by Country

Trials by Country for torsemide
Location Trials
United States 35
India 3
Brazil 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for torsemide
Location Trials
Missouri 3
Texas 3
New York 2
North Carolina 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for torsemide

Clinical Trial Phase

Clinical Trial Phase for torsemide
Clinical Trial Phase Trials
Phase 4 6
Phase 3 1
Phase 2 1
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for torsemide
Clinical Trial Phase Trials
Completed 11
Recruiting 4
Terminated 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for torsemide

Sponsor Name

Sponsor Name for torsemide
Sponsor Trials
Sarfez Pharmaceuticals, Inc. 3
Roxane Laboratories 2
Anapharm 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for torsemide
Sponsor Trials
Industry 14
Other 12
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson
AstraZeneca
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.